EARSAltamira Therapeutics Ltd


$ 1.09 $ 0.00 (0 %)    

Friday, 28-Jun-2024 11:13:37 EDT
QQQ $ 479.98 $ -2.50 (-0.52 %)
DIA $ 391.11 $ -0.43 (-0.11 %)
SPY $ 544.70 $ -2.15 (-0.39 %)
TLT $ 91.77 $ -1.74 (-1.86 %)
GLD $ 215.03 $ 0.02 (0.01 %)
$ 1.11
$ 1.09
$ 0.00 x 0
$ 0.00 x 0
$ 1.09 - $ 1.09
$ 1.05 - $ 17.20
70,962
na
na
$ 1.16
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 auris-medical-highlights-publication-of-data-from-preclinical-studies-with-bentrio-nasal-spray-in-prevention-and-mitigation-of-sars-cov-2-showing-up-to-99-reduction-of-sars-cov-2-viral-titer-with-prophylactic-treatment-vs-controls

Bentrio™ formulation well tolerated in vitro on human nasal epithelium   Up to 99% reduction of SARS-CoV-2 viral titer with...

 auris-medical-to-develop-kras-targeting-rna-treatment-for-colorectal-cancer-as-first-therapeutic-indication-for-oligophore-technology

Treatment of KRAS-driven colorectal cancer selected as first therapeutic indication for OligoPhore™ platform Company to laun...

 auris-medical-announces-significant-inhibition-of-tumor-growth-with-oligophore-sirna-targeting-nf-b-in-murine-model-of-adult-t-cell-leukemia--lymphoma

Auris Medical Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-κB in Murine Model of Adult T...

 why-auris-medical-stock-is-moving-today

Auris Medical Holding Ltd (NASDAQ: EARS) shares are trading higher by 12.7% at $4.16 Thursday morning after the company announc...

 the-daily-biotech-pulse-merck-completes-organon-spin-off-auris-repositions-as-rna-therapeutic-company-with-trasir-purchase-replimunes-readout

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

 auris-medical-acquires-trasir-therapeutics-purchase-price-comprises-of-077m-shares

Auris Medical Holding Ltd. (NASDAQ:EARS), a clinical-stage company dedicated to developing therapeutics that address important ...

 auris-medical-says-starting-preparations-for-covid-19-trial-with-bentrio-in-india

Auris Medical Holding Ltd. (NASDAQ:EARS), a clinical-stage company dedicated to developing therapeutics that address important ...

 auris-medical-announces-completion-of-bentrio-conformity-assessment-procedure-for-marketing-in-eu

Auris Medical Holding Ltd. (NASDAQ:EARS), a clinical-stage company dedicated to developing therapeutics that address important ...

 auris-medical-falls-to-support-and-rallies

Since late January, each time shares of Auris Medical Holding Ltd. (NASDAQ: EARS) fell to $2.80 a rally followed. This happened...

 70-biggest-movers-from-friday
70 Biggest Movers From Friday
05/10/2021 09:24:38

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares gained 43.4% to close at $3.50 on Friday.

Core News & Articles

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 77% to $4.321.

 auris-medical-says-meets-primary-efficacy-endpoint-in-clinical-evaluation-in-allergic-rhinitis

Auris Medical Provides Update on Bentrio Program in Allergy BentrioTM meets primary efficacy endpoint in clinical evaluation...

 46-biggest-movers-from-yesterday
46 Biggest Movers From Yesterday
04/21/2021 09:12:27

Gainers

 48-biggest-movers-from-yesterday
48 Biggest Movers From Yesterday
04/15/2021 09:58:20

Gainers Alkami Technology, Inc. (NASDAQ: ALKT) shares surged 43.3% to settle at $43.00 on Wednesday after the company priced...